These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6337707

  • 1. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC, Ritz J, Lipton JM, Feeney M, Sallan SE, Nathan DG, Schlossman SF.
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [Abstract] [Full Text] [Related]

  • 2. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
    Nakamura H, Hirayama F, Tatsumi Y, Tani Y, Kubota Y, Kanakura Y, Oguma S, Ueda T, Shibata H, Masaoka T.
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
    [Abstract] [Full Text] [Related]

  • 3. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
    Sao H, Morishima Y, Ueda R, Yoshikawa S, Kodera Y, Ohno R, Takahashi T.
    Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
    [Abstract] [Full Text] [Related]

  • 4. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y, Sao H, Ueda R, Morishita Y, Murase T, Kodera Y, Ohno R, Tahara T, Yoshikawa S, Kato Y.
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [Abstract] [Full Text] [Related]

  • 7. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC, Admiraal LG, van Leeuwen EF, Kerr JM, von dem Borne AE, Tetteroo PA.
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mouse L1210V leukemia as a model to analyse efficiency of leukemic cell elimination by immunotoxin, antibody and complement, and cytostatic agents.
    Paprocka M, Wiedlocha A, Radzikowski C.
    In Vivo; 1990 Jan; 4(3):209-13. PubMed ID: 2133264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V, Ritz J, Basala M, Schlossman SF.
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heparin inhibition of antibody-dependent complement-mediated lysis.
    Wesolowski J, Ault K, Houghton R, Parkman R.
    Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
    Bai Y, Piao XH, Luo QL, Mao BZ.
    Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
    Hu ZB, Yu ZF, Qiao CN, Ma WL.
    Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.